CORCEPT THERAPEUTICS INC
public$CORT View Live Feed →
Total Raised
--
Contracts
--
Patents
1
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
TREATMENT OF ADRENOCORTICAL CARCINOMA WITH SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS (SGRMS) AND ANTIBODY CHECKPOINT INHIBITORS
US 12648943 Jun 9, 2026
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Congressional Trades in $CORT
No disclosed congressional trades found in $CORT.
Insider Trades (Form 4)
GRANTChief Development Officer
Guyer William
$18,594328 shares Sep 4, 2026
SELLSee Remarks
Maduck Sean
$3,097,76050,417 shares Sep 4, 2026
GRANTChief Financial Officer
Mokari Atabak
$27,211378 shares Sep 4, 2026
GRANTChief Business Officer
Robb Gary Charles
$28,912419 shares Sep 4, 2026
SELLPresident, Oncology
Vieira Roberto Wandenkolk
$7,749,720117,044 shares Sep 4, 2026
GRANTSee Remarks
Lyon Joseph Douglas
$22,903332 shares Sep 4, 2026
SELLChief Development Officer
Guyer William
$498,6677,400 shares Aug 6, 2026
SELLSee Remarks
Maduck Sean
$2,496,99740,610 shares Aug 5, 2026
Key People
Vieira Roberto Wandenkolk
President, Oncology
Insider
Lyon Joseph Douglas
See Remarks
Insider
Maduck Sean
See Remarks
Insider
Mokari Atabak
Chief Financial Officer
Insider
Guyer William
Chief Development Officer
Insider
WILSON JAMES N
Director
BoardInsider
Robb Gary Charles
Chief Business Officer
Insider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro